COGA review of WCAG 3: Pre-reads and agenda for April 30th meeting

Hey there,

Here's the pre-read for the "COGA review of WCAG 3" meeting on April <https://us02web.zoom.us/j/85338141203?pwd=Tk1LZXI0TUlYT29QVTdXQXpPQ2h1QT09> 30th<https://us02web.zoom.us/j/85338141203?pwd=Tk1LZXI0TUlYT29QVTdXQXpPQ2h1QT09>, when we'll have our initial discussion of the “Text and Wording" section.

Text and Wording Github Drafts<https://docs.google.com/document/d/1jLkvaCNxpk1xJ-yuyTWciizRe3GkGWPc-3yu6ZJLIqg/edit?pli=1&tab=t.a8kl7lsifug#heading=h.z5n7lhr2gjnu> <https://docs.google.com/document/d/1jLkvaCNxpk1xJ-yuyTWciizRe3GkGWPc-3yu6ZJLIqg/edit?pli=1&tab=t.a8kl7lsifug#heading=h.z5n7lhr2gjnu>

Please note:


  *   We are recommending COGA submit 3 GitHub issues.

  *   The 4th GitHub issue on our tab may be needed after our conversation. But, we are still tracking down the history and intent behind that provision.

A couple notes on the reviewing process:

  *   All COGA members are encouraged to add asynchronous comments by end of day April 29th and to come to the April 30th discussion.

  *   We will use our time together on Thursday to align on the draft issues and, when ready, we'll send cleaned-up versions for the task force to vote on.

Thanks in advance for your time, and please let me know if you have any questions.

Len

--
Len Beasley, CPACC, (He, Him)
Domain Expert, Accessibility & Inclusive Design
W3C Accessibility Guidelines Working Group, COGA Task Force

918 630 5419
Colorado (MT)
[Aetna]
CONFIDENTIALITY NOTICE: This communication and any attachments may contain confidential and/or privileged information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please notify the sender immediately by email or telephone and destroy all copies of this communication and any attachments.

 NOTICE TO RECIPIENT OF INFORMATION:
This e-mail may contain confidential or privileged information. If you think you have received this e-mail in error, please advise the sender by reply e-mail and then delete this e-mail immediately.  

This e-mail may also contain protected health information (PHI) with information about sensitive medical conditions, including, but not limited to, treatment for substance use disorders, behavioral health, HIV/AIDS, or pregnancy. This type of information may be protected by various federal and/or state laws which prohibit any further disclosure without the express written consent of the person to whom it pertains or as otherwise permitted by law. Any unauthorized further disclosure may be considered a violation of federal and/or state law. A general authorization for the release of medical or other information may NOT be sufficient consent for release of this type of information.

Thank you. Aetna